实践简报第182号摘要:遗传性乳腺癌-卵巢癌综合征
遗传性乳腺癌-卵巢癌综合征是一种遗传性癌症易感综合征,特征为多个家庭成员患乳腺癌、卵巢癌或两者兼有。本实践简报聚焦于与遗传性乳腺癌-卵巢癌综合征相关的主要基因突变BRCA1和BRCA2,并简要讨论其他相关基因。临床基因检测可更精确地识别遗传性乳腺癌和卵巢癌风险增高的女性,对此类个体可采取筛查和预防策略以降低风险。
要点
- 遗传性乳腺癌-卵巢癌综合征以多个家庭成员患乳腺癌、卵巢癌或两者兼有为特征。
- 临床基因检测可更精确识别遗传性乳腺癌和卵巢癌风险增高的女性。
- 若妇产科医生不具备癌症遗传学知识或专长以适当咨询患者,应考虑转诊至遗传咨询师、妇科或肿瘤内科医生或其他遗传学专家。
核心结论
- 妇产科医生在遗传性乳腺癌-卵巢癌综合征女性的识别和管理中发挥重要作用。
- 若妇产科医生或其他妇科护理提供者不具备必要的癌症遗传学知识或专长以适当咨询患者,应考虑转诊至遗传咨询师、妇科或肿瘤内科医生或其他遗传学专家。
研究设计与样本
- 本实践简报由妇产科实践公报委员会制定,聚焦于与遗传性乳腺癌-卵巢癌综合征相关的主要基因突变BRCA1和BRCA2,并简要讨论其他相关基因。
主要发现
- 遗传性乳腺癌-卵巢癌综合征是一种遗传性癌症易感综合征,特征为多个家庭成员患乳腺癌、卵巢癌或两者兼有。
- 基于当代对卵巢癌起源和管理的理解,为简便起见,本文档中卵巢癌也指输卵管癌和原发性腹膜癌。
- 临床基因检测可更精确地识别遗传性乳腺癌和卵巢癌风险增高的女性,对此类个体可采取筛查和预防策略以降低风险。
- 正在发现更多赋予乳腺癌、卵巢癌和其他类型癌症不同风险的基因,并且正在开发用于基因检测的新技术。
关键数值与推荐
- 若妇产科医生或其他妇科护理提供者不具备必要的癌症遗传学知识或专长以适当咨询患者,应考虑转诊至遗传咨询师、妇科或肿瘤内科医生或其他遗传学专家。
临床怎么用
- 妇产科医生在遗传性乳腺癌-卵巢癌综合征女性的识别和管理中发挥重要作用。
- 若妇产科医生或其他妇科护理提供者不具备必要的癌症遗传学知识或专长以适当咨询患者,应考虑转诊至遗传咨询师、妇科或肿瘤内科医生或其他遗传学专家。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hereditary breast and ovarian cancer syndrome is an inherited cancer-susceptibility syndrome characterized by multiple family members with breast cancer, ovarian cancer, or both. Based on the contemporary understanding of the origins and management of ovarian cancer and for simplicity in this document, ovarian cancer also refers to fallopian tube cancer and primary peritoneal cancer. Clinical genetic testing for gene mutations allows more precise identification of those women who are at an increased risk of inherited breast cancer and ovarian cancer. For these individuals, screening and prevention strategies can be instituted to reduce their risks. Obstetrician-gynecologists play an important role in the identification and management of women with hereditary breast and ovarian cancer syndrome. If an obstetrician-gynecologist or other gynecologic care provider does not have the necessary knowledge or expertise in cancer genetics to counsel a patient appropriately, referral to a genetic counselor, gynecologic or medical oncologist, or other genetics specialist should be considered (1). More genes are being discovered that impart varying risks of breast cancer, ovarian cancer, and other types of cancer, and new technologies are being developed for genetic testing. This Practice Bulletin focuses on the primary genetic mutations associated with hereditary breast and ovarian cancer syndrome, BRCA1 and BRCA2, but also will briefly discuss some of the other genes that have been implicated.
引用
- Practice Bulletin No. 182 Summary: Hereditary Breast and Ovarian Cancer Syndrome. Obstet Gynecol. 2017. PMID: 28832475. doi:10.1097/AOG.0000000000002285
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。